BNR

Burning Rock Biotech Ltd

Latest Form 4:Purchase$216KbyHan Yusheng (Director) · filed Jul 2, 2026

Burning Rock Biotech Ltd (BNR) has 2 SEC Form 4 filings (8 transaction rows) in the rolling window, disclosed by 1 distinct insider. Most recent filing: Jul 2, 2026.

The most active filer is Director Han Yusheng with 8 filings. Insiders have net bought $11.6M over the trailing 6 months. The largest single insider purchase in this window was $5.5M by Director Han Yusheng on Mar 31, 2026.

  • Industry:Medical - Diagnostics & Research
  • CEO:Yusheng Han
  • Employees:674
  • HQ:Guangzhou, CN
  • IPO:2020-06-12

Insider Buying

$11.6M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Unique Insiders

1

in the rolling window

Source
Han YushengFirst in 3 months
Purchase$216KJul 2SEC ↗
Han YushengFirst in 3 months
Purchase$1.9MJul 2SEC ↗
Han YushengFirst in 3 months
Purchase$1000KJul 2SEC ↗
Han YushengFirst in 3 months
Purchase$780KJul 2SEC ↗
Han YushengFirst in 3 months
Purchase$45KJul 2SEC ↗
Han YushengFirst in 3 months
Purchase$2.0MJul 2SEC ↗
Han YushengFirst in 3 months
Purchase$199KJul 2SEC ↗
Han YushengFirst filing
Purchase$5.5MApr 2SEC ↗

Related companies

Burning Rock Biotech Ltd is in the Healthcare sector.